Biomarkers of inflammation in infants with cystic fibrosis

BACKGROUND: There are urgent needs for clinically relevant biomarkers to identify children with cystic fibrosis (CF) at risk for more progressive lung disease and to serve as outcome measures for clinical trials. Our objective was to investigate three targeted biomarkers in a population of asymptoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Laguna, Theresa A., Williams, Cynthia B., Nunez, Myra G., Welchlin-Bradford, Cole, Moen, Catherine E., Reilly, Cavan S., Wendt, Chris H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759377/
https://www.ncbi.nlm.nih.gov/pubmed/29310632
http://dx.doi.org/10.1186/s12931-017-0713-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759377/
https://www.ncbi.nlm.nih.gov/pubmed/29310632
http://dx.doi.org/10.1186/s12931-017-0713-8

Ejemplares similares